Charles Boulakia is a partner of Ridout & Maybee LLP in the firm’s Toronto office. His practice is principally directed towards the preparation and prosecution of patent applications in the biotechnology, chemistry, biofuel, oil and gas and pharmaceutical areas. Charles provides his clients with IP due diligence, validity, and freedom to operate opinions. Charles also drafts and negotiates license agreements and occasionally advises on food and drug regulatory law, including product labelling and advertising. Previous to his career in law, Charles worked briefly in venture capital, “big pharma”, and for the American Association for the Advancement of Science.
